close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar18Point21
Implied share price

Buy Undervalued by 64.8%

5% margin of safety What's this?

EV / EBITDA
Use Average
CLC.U
CML Healthcare Income Fund
DNA
Genentech, Inc.
Change
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
CELG
Celgene Corporation
Change
13.88 9.26 17.08 7.19 7.37 22.25
All amounts in millions
from last financial year
         
Implied Share Price $18.21 $77.79 $99.38 $63.53 $35.68
Market Cap 990 100,042 50,712 28,530 24,479
Net Debt 298 -3,369 -2,841 -495 -2,975
Enterprise Value (EV) 1,289 96,673 47,871 28,034 21,504
Revenue 518 13,418 14,642 7,011 2,689
EBITDA 139 5,661 6,658 3,802 966
Percent 26.8 % 42.2 % 45.5 % 54.2 % 35.9 %
EBIT 105 5,069 5,609 3,589 841
Percent 20.3 % 37.8 % 38.3 % 51.2 % 31.3 %
Balance Sheet          
Total Assets 997 21,787 39,629 9,698 5,389
Total Liabilities 447 6,116 16,962 3,331 994
Shareholders Equity 550 15,671 22,667 6,367 4,394.606

Comments

No comments yet. Login to comment.